课题基金 / 基金详情

IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION

IMPAIRED TUMOR IMMUNITY DURING H PYLORI INFECTION
幽门螺杆菌感染期间肿瘤免疫力受损
批准号:
6517381
负责人:
VICTOR E. REYES
金额:
$26.8万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-06-01 至 2004-05-31

项目摘要

项目成果

VICTOR E. REYES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Helicobacter pylori is an important pathogen which plays the major role in chronic gastritis, gastric and duodenal ulcers and gastric carcinomas. Although H pylori infection of the gastric epithelium elicits immune responses, insight into the mechanisms that regulate the development of those responses is limited. Recent studies have suggested that mucosal epithelial cells are active participants in immune responses to mucosal pathogens. The antral gastric epithelium constitutively expresses class II MHC molecules, and our cells have shown that these epithelial cells express other important markers which are required by antigen presenting cells. We noted that gastric epithelial cells in vitro and in vivo expressed the CD86 co-stimulatory molecule and this expression increased in parallel with the rise of local CD4+ T cell numbers and epithelial class II MHC expression increased in parallel with the rise of local CD4+ T cell numbers and epithelial c;ass II MHC expression during infection with H. pylori. Our most recent studies suggest that H pylori antigens are endocytosed by gastric epithelial cells and transported into endosomes that contain HLA-DM, a molecule which is essential in class II MHC-mediated antigen presentation and immunity to pathogens. Thus, gastric epithelial cells possess key functional elements of antigen presenting cells. Since antigen processing and presentation are pivotal events in the development of an immune response, our observations have led us to hypothesize that gastric epithelial cells are central regulators of the inflammatory and immunologic responses during H. pylori infection and that the nature of those responses is influenced by the bacteria. To examine this hypothesis we will address the following specific aims, as natural extensions of the studies performed during the initial period of funding. 1) Characterize the mechanisms of antigen internalization by gastric epithelial cells. In this aim we will (a) characterize the H. pylori antigens that are selectively internalized by human gastric epithelial cells and the mechanisms that promote their uptake; (b) define how internalized H. pylori antigens may alter various steps in the normal antigen processing (steps) and (c) identify the H. pylori peptides that are selective for presentation to T cells by gastric epithelial cells. 2) Characterize the mechanisms that allow gastric epithelial cells to influence CD4+ T cell function. In this aim we will (a) define the distribution of class II MHC in polarized gastric epithelial cells and (b) characterize the expression and function of Ii-CS, an essential co- receptor for CD44 on T cells, by human gastric epithelial cells. The overall goal of these studies is to better understand the interactions between H. pylori, the gastric epithelium and immune cells that determine the outcome of the infection. The studies may help explain why H. pylori infection persists and whether mechanisms that allow H. pylori to evade immune defenses may also permit the associated neoplasms to evade immune surveillance. Understanding the molecular basis for the regulation of the local immune response to natural infection will also facilitate the development of therapeutic or prophylactic vaccines against this clinically important pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colonic myofibroblast activation of PD-1 pathways in inflammatory bowel diseases
Immune Evasion by H. pylori
Protein Biomarkers of Gastric Cancer
Protein Biomarkers of Gastric Cancer
国内基金
海外基金
高脂饮食诱导肠道微生物Helicobacter促进肠癌发生的分子机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55.7万元
  • 批准年份:
    2021
  • 负责人:
    朱亚辉
  • 依托单位:
研发纳米金材料改良免疫探测器用于定量分析污水中幽门螺旋杆菌(Helicobacter pylori, Hp)的新型流行病学研究
  • 批准号:
    LQ22B050004
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    卢鼎南
  • 依托单位:
肥胖对Helicobacter suis感染后胃MALT淋巴瘤发生的影响及其炎性机制的研究
  • 批准号:
    81572320
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    杨林
  • 依托单位: